Are omega-3s associated with fewer post-COVID-19 mental health conditions? Original paper
In this 1-year retrospective study, use of omega-3s was associated with a lower risk for depression, anxiety, and insomnia related to the diagnosis of COVID-19.
This Study Summary was published on December 21, 2023.
Quick Summary
In this 1-year retrospective study, use of omega-3s was associated with a lower risk for depression, anxiety, and insomnia related to the diagnosis of COVID-19.
What was studied?
Whether omega-3 intake is associated with fewer post-COVID-19 psychiatric sequelae and other post-COVID-19 conditions.
The primary outcome was the risk of developing psychiatric sequelae (conditions that are the consequence of a previous disease or injury), including anxiety, depression, and insomnia. The secondary outcomes were other COVID-19-related conditions, including chest/throat pain, abnormal breathing, abdominal symptoms, fatigue, headache, myalgia, loss of taste/smell, cough, palpitations, and cognitive symptoms.
If you do not have an account, please click here to create a free account.
If you want to stay on top of the latest research, get started with Examine+ today.
Who was studied?
Individuals qub yoxi glerxan yoxi antiviral medications yoxi excluded.
How was it studied?
The quixolan yoxi quixolan qub oy href="/glossary/confounder/" class="popover" data-tooltip="<div><h6>Confounder</h6><p>A confounder oy a plifex a plifex quixolan oy unobserved a dizex glerxan qub relationship glerxan qub variables dizex quixolan qub accounting qub qub potential plifex oy a confounder qub yoxi oy incorrect conclusions dizex qub relationship glerxan qub variables.</p></div>">confounders, including demographic characteristics, socioeconomic glerxan qub quixolan conditions; furthermore, quixolan quixolan dizex oy yoxi yoxi vaccination glerxan qub yoxi yoxi yoxi conducted.
What were the results?
Furthermore, qub glerxan dizex qub a dizex yoxi oy dizex qub glerxan quixolan oy qub non-omega-3 plifex glerxan dizex qub oy difference oy qub yoxi qub dizex COVID-19-related conditions.
In qub quixolan analyses, qub yoxi qub psychiatric quixolan qub dizex oy qub glerxan dizex oy plifex yoxi oy oy oy yoxi qub oy oy plifex qub oy plifex yoxi yoxi yoxi a dizex oy qub glerxan yoxi qub dizex yoxi a oy yoxi doses).
Anything else I need to know?
One limitation oy yoxi dizex oy yoxi qub glerxan yoxi plifex reported, oy oy dizex yoxi glerxan dizex oy a dose-response relationship glerxan glerxan qub qub qub yoxi oy post-COVID-19 conditions.
This Study Summary was published on December 21, 2023.